about
Brain-gut axis in the pathogenesis of Helicobacter pylori infectionTreatment with double dose of omeprazole increases β-endorphin plasma level in patients with coronary artery disease.Contrast-enhanced ultrasonography for the determination of Crohn's disease activity - preliminary experience.Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.[Serine protease inhibitors in plasma of patients with ulcerative colitis]Lipoprotein(a) in alcohol-dependent male patients during a six-month abstinence period.The effect of eight weeks of rabeprazole therapy on nitric oxide plasma level and esophageal pH and motility and motility nitric oxide plasma level in patients with erosive esophagitis.Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease.Improvement in clinical course and laryngeal appearance in selected patients with chronic laryngitis after eight weeks of therapy with rabeprazole.[Gastroesophageal acid reflux as a causative factor of paroxysmal atrial fibrillation].Blood glucose and lipid concentrations after overload are not associated with the risk of alcohol relapse.Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation[The relationship between oesophageal and gastric pH during 24-hours pH-metry in patients diagnosed with atypical chest pain].[Hypersensitivity reactions in patients with irritable colon syndrome][Type I allergy and indices of immune response in patients with ulcerative colitis]Naltrexone exerts a favourable effect on plasma lipids in abstinent patients with alcohol dependence[Relationship between results of electrocardiographic exercise tests and intraesophageal pH in men with atypical chest pain][Blood coagulation activation in patients with ulcerative colitis][Gastroesophageal reflux disease is an important factor in differential diagnosis of chest pain][Oxygen metabolism disturbances in the pathogenesis of gastric and duodenal diseases]Differences in esophageal corpus motility in patients with pathological and non-pathological gastroesophageal reflux[Effect of Helicobacter pylori infection on the gastroesophageal reflux in patients with atypical chest pain]The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial[Influence of Helicobacter pylori infection on the results of 24-hour gastric pH-metry in patients diagnosed because of atypical chest pain][Clinical value of skin tests using bacterial extracts]
P50
Q33594833-FB073A1C-8F1B-4CC6-B5E8-5BF548F23904Q35762019-FCDEEF6E-5924-4790-8D66-6F25D1A47E31Q37694717-B102B59B-06E3-4CA3-A01F-035116D51DBCQ38211000-4249A6C4-DB59-4BB1-858E-72F68D584A04Q43689584-6618FF1C-2271-48ED-9C75-A1955C4FC780Q44360208-901DEB65-8494-45D8-8BC2-2BE75201EDD9Q44737445-A8B9AA60-5A3A-4D22-99A9-85ACD2C0A20FQ45029847-2E2CD665-E8BD-4EDD-8DAC-C138099B61B6Q45078311-EB2D16E3-7C19-4597-B75A-4E5A212EBC99Q46426241-0541F093-0C52-43C4-A0FD-289E26E38475Q51287720-D02DE737-98F6-4487-9580-8ECD518A87B4Q58085066-8B2C2CCD-424A-4EAA-A145-52C443E61500Q64917439-AC4151BB-2F82-4D12-9685-403A57ED0ED9Q72058499-1B43A939-C752-4618-AE0F-D547181CE5BFQ72058503-3DC2F0AB-099E-4CDD-B2C3-BFCAB4225794Q73469509-7720A7CB-26F7-4BC0-8662-5538ECC581FCQ73581662-E9A197B9-9110-4A8E-AE7A-4B4387BDB41CQ73581717-D7C68D95-B6A7-4BBD-BC8C-DB860D2025CEQ74194103-132F7EEA-6FF6-491C-9407-F8ED8D28E359Q78110825-E8C2D7BD-85E4-4A4C-B3EB-EA96797A3F58Q80186359-FCC5EF07-F34E-4414-A8D8-F7E3B51F8E9FQ80272803-1B35F3A8-5D4C-476C-8440-31DCDC879B2AQ80774966-302EA1E4-B058-491B-89EB-59C60BAC869FQ82849240-106E6BBB-5A6E-436A-BA53-4A44D83D7329Q93582976-03384521-468C-44DF-89CE-B5EAAB8BF2D1
P50
description
researcher
@en
name
Kłopocka M
@nl
Maria Kłopocka
@en
Maria Kłopocka
@pl
type
label
Kłopocka M
@nl
Maria Kłopocka
@en
Maria Kłopocka
@pl
altLabel
Kłopocka M
@en
prefLabel
Kłopocka M
@nl
Maria Kłopocka
@en
Maria Kłopocka
@pl
P106
P31
P496
0000-0003-2149-5826